RBC Life Sciences (OTCBB: RBCL) announced that strategic business growth veteran Robert A. Kaiser has joined it board of directors. The news release says his 30 years of executive-level leadership comes to the board “at a time when RBC Life Sciences is focusing on aggressive domestic and international expansion.”
“Robert has an impressive entrepreneurial background and strategic experience in profit and revenue expansion and shareholder development that will serve the company as it positions itself moving forward,” said RBC Life Sciences President John Price. “Robert’s expertise will be invaluable as we redouble growth efforts within the United States and abroad.”
Kaiser is chairman and CEO of CLST Holdings, the public company remaining from the 2007 sale of Cellstar Inc., an international logistics and distribution firm serving the communications industry. He was CEO of Mobile Star, CEO and CFO of Skytel/Worldcom from 1996 to 2001, CFO of Cingular/ Southwestern Bell Mobile Systems from 1986 to 1996, and CFO of LTV Energy from 1976 to 1985.
Comprised of an advanced wound care and pain management products subsidiary and a nutritional supplements subsidiary, RBC Life Sciences grew nearly 25 percent in 2007.
“RBC Life Sciences has a compelling story of helping people globally improve quality of life,” Kaiser said. “Its nutritional supplements subsidiary of the same name offers one of the most-respected array of products in the industry.”
He also pointed to RCBL’s wound care and pain management subsidiary — MPM Medical Inc. — as continuing to gain praise. “I am proud to join RBC’s board to help it become the household name that it deserves,” he said.
Let us hear your thoughts below:
